Sanofi and Regeneron's Dupixent product wins Chinese approval
June 19, 2020 at 07:40 AM EDT
Healthcare companies Sanofi and Regeneron said on Friday that their Dupixent product had won regulatory approval in China to treat adults suffering from moderate-to-severe atopic dermatitis, often known as eczema.